Behavioral
HEART
HEART is a behavioral intervention with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Withdrawn1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
withdrawn125%
terminated125%
completed250%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Cardio-visual Stimulation in Augmented Reality for Pain Reduction
NCT05085821
terminatednot_applicable
Longitudinal Effects of a Sexual Health Intervention: HEART
NCT04156516
withdrawnnot_applicable
A Trial of a Multi-component Individualized Telephone-based Support Intervention for Adult-child Caregivers Caring for Parents With Dementia
NCT03378050
completednot_applicable
Reducing HIV Risk Among Adolescents: Evaluating HEART for Teens
NCT03453515
Clinical Trials (4)
Showing 4 of 4 trials
NCT05085821Not Applicable
Cardio-visual Stimulation in Augmented Reality for Pain Reduction
NCT04156516Not Applicable
Longitudinal Effects of a Sexual Health Intervention: HEART
NCT03378050Not Applicable
A Trial of a Multi-component Individualized Telephone-based Support Intervention for Adult-child Caregivers Caring for Parents With Dementia
NCT03453515Not Applicable
Reducing HIV Risk Among Adolescents: Evaluating HEART for Teens
All 4 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 4